A new study published in NEJM Evidence suggests that ulipristal acetate, the active ingredient in the contraceptive Ella, could be a potential substitute for the abortion pill mifepristone. The study involved 133 women who took a higher dose of ulipristal acetate followed by misoprostol, resulting in a 97 percent completion rate for terminating pregnancies. The findings have raised concerns about blurring the line between emergency contraception and abortion, potentially impacting the politics surrounding reproductive health.
Full Article
Loading PerspectiveSplit analysis...
